Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07559227 · ClinicalTrials.gov registry record · NA
Gut, Immune, and Vascular Health in Metabolically Healthy Obesity
A NA study, sponsored by Ball State University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07559227: Recruiting NA study, sponsored by Ball State University.
NCT07559227 is a NA study that is actively recruiting participants, run by Ball State University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07559227, a NA study, is actively recruiting participants, sponsored by Ball State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The investigators seek to better understand how a single high-fat meal impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity" (obesity and largely normal cardiometabolic profile) and "metabolically healthy normal-weight individuals." Second, the investigators seek to understand how a prebiotic fiber (inulin) impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity."
Primary Outcome
Part 1: The investigators will measure lipopolysaccharide binding protein at baseline and , 1-, 2-, 3-, 4-, 5-, and 6-hours after the meal. Part 2: The investigators will measure lipopolysaccharide binding protein at baseline and 2-, 4-, and 6-weeks post intervention.
Interventions
- DIETARY_SUPPLEMENT Maltodextrin (Placebo)
- OTHER High-fat meal
- DIETARY_SUPPLEMENT Inulin Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07559227 shows while recruiting
NCT07559227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Maltodextrin (Placebo) is the first listed.
NCT07559227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07559227 about?
NCT07559227 is a clinical study titled "Gut, Immune, and Vascular Health in Metabolically Healthy Obesity". The investigators seek to better understand how a single high-fat meal impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity" (obesity and largely normal cardiometabolic profile) and "metabolically healthy normal-weight individuals." Second, the investigators ...
What is the current status of trial NCT07559227?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-03-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07559227?
The interventions under investigation include: Maltodextrin (Placebo) (DIETARY_SUPPLEMENT), High-fat meal (OTHER), Inulin Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07559227?
This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07559227's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI